Therapeutic Potential of Polyamidoamine Dendrimer for Amyloidogenic Transthyretin Amyloidosis-Reference-Cited by-同舟云学术

Therapeutic Potential of Polyamidoamine Dendrimer for Amyloidogenic Transthyretin Amyloidosis

Published:2019-03-26 Issue:5 Volume:10 Page:2584-2590
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Inoue Masamichi¹,Ueda Mitsuharu,Higashi Taishi,Anno Takayuki,Fujisawa Kazuya,Motoyama Keiichi,Mizuguchi Mineyuki²,Ando Yukio,Jono Hirofumi^ORCID,Arima Hidetoshi¹^ORCID

Affiliation:

1. Program for Leading Graduate Schools ‘Health Life Science: Interdisciplinary and Glocal Oriented (HIGO) Program’, Kumamoto University, Kumamoto 860-8555, Japan

2. Laboratory of Structual Biology, Graduate School of Medicine and Pharmaceutical Sciences, Toyama University, 2630 Sugitani, Toyama 930-0194, Japan

Funder

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.9b00059

Reference55 articles.

1. Recent advances in transthyretin amyloidosis therapy

2. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study